Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review

Hamid, H. A., Ramli, A. N., & Yusoff, M. M. | Frontiers in Pharmacology | 28 February 2017

22-azidosalvinorin A exhibits antidepressant-like effect in mice

Fajemiroye, J. O., Prabhakar, P. R., da Cunha, C. L., Costa, E. A., & Zjawiony, J. K. | European Journal of Pharmacology | 17 February 2017

Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus

Ardalan, M., Rafati, A. H., Nyengaard, J. R., & Wegener, G. | British Journal of Pharmacology | 8 February 2017

Sub-anesthetic doses of ketamine exert antidepressant-like effects and upregulate the expression of glutamate transporters in the hippocampus of rats

Zhu, X., Ye, G., Wang, Z., Luo, J., & Hao, X. | Neuroscience Letters | 3 February 2017

Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task

Rychlik, M., Bollen, E., & Rygula, R. | Psychopharmacology | 1 February 2017

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. | Neuropsychopharmacology | 27 January 2017

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial

Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M., Pessoa, J., ... & Tofoli, L. | bioRxiv | 27 January 2017

Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion

da Frota Ribeiro, C. M., Sanacora, G., & Ostroff, R. | Biological Psychiatry | 23 January 2017

The fibrinolytic system: A new target for treatment of depression with psychedelics

Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R. B. S., & Idell, S. | Medical Hypotheses | 23 January 2017

Administration of ketamine for unipolar and bipolar depression

Kraus, C., Rabl, U., Vanicek, T., Carlberg, L., Popovic, A., Spies, M., ... & Willeit, M. | International Journal of Psychiatry in Clinical Practice | 18 January 2017

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature

Grady, S. E., Marsh, T. A., Tenhouse, A., & Klein, K. | Mental Health Clinician | 1 January 2017

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Malcolm, B. J., & Lee, K. C. | Mental Health Clinician | 1 January 2017

Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Ketamine Mechanism of Action: Separating the Wheat from the Chaff

Gould, T. D., Zanos, P., & Zarate, C. A. | Neuropsychopharmacology | 1 January 2017

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

Breckenridge, A., & Grobbee, D. E. | Journal of psychopharmacology | 6 December 2016

Psilocybin for depression and anxiety associated with life-threatening illnesses

McCorvy, J. D., Olsen, R. H., & Roth, B. L. | Journal of psychopharmacology | 6 December 2016

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder

Vande Voort, J. L., Ballard, E. D., Luckenbaugh, D. A., Bernert, R. A., Richards, E. M., Niciu, M. J., ... & Zarate, C. A. | Journal of clinical psychiatry | 6 December 2016

Harmine stimulates proliferation of human neural progenitors

Dakic, V., de Moraes Maciel, R., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. | PeerJ | 6 December 2016

Psilocybin and palliative end-of-life care

Shelton, R. C., & Hendricks, P. S. | Journal of Psychopharmacology | 1 December 2016

Psilocybin in end of life care: Implications for further research

Summergrad, P. | Journal of Psychopharmacology | 1 December 2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. | Journal of Psychopharmacology | 1 December 2016

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Su, Z. | Journal of Psychopharmacology | 1 December 2016

Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future

Nutt, D. | Journal of Psychopharmacology | 1 December 2016

Ketamine for Treatment-Resistant Depression

Mathew, S. J., & Zarate Jr, C. A. | Springer International Publishing | 1 December 2016

The Therapeutic Potential of Ayahuasca

Coe, M. A., & McKenna, D. J. | Springer International Publishing | 1 December 2016